Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CCI 779. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1942476A details enzymatic acylation of rapamycin. Offers high yield, mild conditions, and eliminates heavy metal catalysts for pharmaceutical intermediates.
Patent CN102796115B reveals a streamlined temsirolimus preparation method offering high yield and cost reduction in API intermediate manufacturing for global supply chains.
Patent CN1829722A details a regioselective boronate route for CCI-779, eliminating chromatography for cost-effective API intermediate manufacturing.